A dysbiotic microbiome triggers T(H)17 cells to mediate oral mucosal immunopathology in mice and humans.
A dysbiotic microbiome triggers T(H)17 cells to mediate oral mucosal immunopathology in mice and humans.
复制标题
DOI:
10.1126/scitranslmed.aat0797
复制
发表时间:
2018-10-17
影响因子:
17.1
通讯作者:
Moutsopoulos NM
中科院分区:
文献类型:
--
作者:
Dutzan N;Kajikawa T;Abusleme L;Greenwell-Wild T;Zuazo CE;Ikeuchi T;Brenchley L;Abe T;Hurabielle C;Martin D;Morell RJ;Freeman AF;Lazarevic V;Trinchieri G;Diaz PI;Holland SM;Belkaid Y;Hajishengallis G;Moutsopoulos NM
Combined human and animal model studies conclusively implicate microbiota-triggered oral mucosal Th17 cells as drivers of local immunopathology and therapeutic targets in periodontitis. Periodontitis is one of the most common human inflammatory diseases, yet the mechanisms that drive immunopathology and could be therapeutically targeted are not well defined. Here, we demonstrate an expansion of resident memory Th17 cells in human periodontitis. Phenocopying humans, Th17 cells expanded in murine experimental periodontitis through local proliferation. Unlike homeostatic oral Th17 cells, which accumulate in a commensal-independent and IL-6-dependent manner, periodontitis-associated expansion of Th17 cells was dependent upon the local dysbiotic microbiome and required both IL-6 and IL-23. Importantly, Th17 cells and associated neutrophil accumulation were necessary for inflammatory tissue destruction in experimental periodontitis. Genetic or pharmacological inhibition of Th17 cell differentiation conferred protection from immunopathology. Studies in a unique patient population with a genetic defect in Th17 cell differentiation established human relevance for our murine experimental studies. Indeed, in the oral cavity, human Th17 cell defects were associated with diminished periodontal inflammation and bone loss, despite increased prevalence of recurrent oral fungal infections. Our study highlights distinct functions of Th17 cells in oral immunity and inflammation and paves the way to a new targeted therapeutic approach for the treatment of periodontitis.
登录
查看更多内容
影响因子:
30.5
作者:
通讯作者:
--
影响因子:
15.9
作者:
Hajishengallis G;Lamont RJ
通讯作者:
Lamont RJ
影响因子:
6.7
作者:
Allam, Jean-Pierre;Duan, Yonggang;Novak, Natalija
通讯作者:
Novak, Natalija
影响因子:
2.2
作者:
Abe, Toshiharu;Hajishengallis, George
通讯作者:
Hajishengallis, George
影响因子:
3.8
作者:
Abusleme L;Moutsopoulos NM
通讯作者:
Moutsopoulos NM